Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Sanofi Cvr (GCVRZ)

0.44 0 (0%)

04-20 10:07

Open:

0.4409

Pre. Close:

0.44

High:

0.4409

Low:

0.44

Volume:

554

Market Cap:

553M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.441 - 0.443

0.443 - 0.445

Low:

0.434 - 0.437

0.437 - 0.439

Close:

0.436 - 0.44

0.44 - 0.444

Technical analysis  (as of: 2018-04-20 4:30:04 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 0.56     One year: 0.65

Support:

Support1: 0.42    Support2: 0.39

Resistance:

Resistance1: 0.48    Resistance2: 0.56

Pivot:

0.44

Moving Averages:

MA(5): 0.44     MA(20): 0.43

MA(100): 0.40     MA(250): 0.39

MACD:

MACD(12,26): 0.01     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 36.51     %D(3): 47.62

RSI:

RSI(14): 59.24

52-Week:

High: 0.49  Low: 0.26  Change(%):

Average Vol(K):

3-Month: 9080  10-Days 8702

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
GCVRZ has closed below upper band by 47.8%. Bollinger Bands are 27.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2017-05-23T17:16:19-04:00
What Happened With The Genzyme CVR Since August 2015

2015-12-07T12:24:49-05:00
Comparing Apples With Oranges

2015-09-09T06:00:00-04:00
7 Fat Years Of Event-Driven Investing, Part II

2015-08-11T10:19:02-04:00
The Future Of GCVRZ

2015-08-01T09:05:33-04:00
Sanofi Lemtrada Sales Disappoint: CVR Milestones Will Not Be Achieved

2015-06-16T10:12:17-04:00
Seeking Alpha On Day 2

2015-02-12T04:43:31-05:00
Seven Fat Years Of Event-Driven Investing

2015-02-11T01:40:58-05:00
CVRs - The Good, The Bad And The Ugly

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

Shares Float (M)

% Held by Insiders

% Held by Institutions

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

PEG Ratio

Profit Margin

27.23

Operating Margin

Return on Assets (ttm)

8.8

Return on Equity (ttm)

15.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.